The trajectory of companies tied to Sildenafil's legacy presents a challenging investment picture . While the initial success generated substantial returns , generic alternatives have significantly eroded https://bookmarkcolumn.com/story21421039/the-copyright-and-pharma-a-speculative-opportunity